Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Assets (2021 - 2025)

Maravai Lifesciences Holdings has reported Return on Assets over the past 5 years, most recently at 0.28% for Q4 2025.

  • Quarterly results put Return on Assets at 0.28% for Q4 2025, down 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.28% (down 6.0% YoY), and the annual figure for FY2025 was 0.26%, down 5.0%.
  • Return on Assets for Q4 2025 was 0.28% at Maravai Lifesciences Holdings, down from 0.24% in the prior quarter.
  • Over the last five years, Return on Assets for MRVI hit a ceiling of 0.27% in Q1 2022 and a floor of 0.37% in Q2 2025.
  • Median Return on Assets over the past 5 years was 0.05% (2023), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Assets: grew 17bps in 2022 and later decreased -29bps in 2023.
  • Maravai Lifesciences Holdings' Return on Assets stood at 0.25% in 2021, then dropped by -12bps to 0.22% in 2022, then plummeted by -134bps to 0.07% in 2023, then plummeted by -208bps to 0.23% in 2024, then dropped by -25bps to 0.28% in 2025.
  • The last three reported values for Return on Assets were 0.28% (Q4 2025), 0.24% (Q3 2025), and 0.37% (Q2 2025) per Business Quant data.